C. Daniel Smith
Research Subjects
C. Daniel Smith has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Horacio J. Asbun
Mayo Clinic Florida
3 shared publications Mauricia Buchanan
Department of Surgery, Mayo Clinic Florida, Jacksonville, FL
3 shared publications- Ross F. Goldberg
Affiliate Professor of Surgery, University of Miami Miller School of Medicine, Miami, FL
3 shared publications - Steven P. Bowers
Department of Surgery, Mayo Clinic, Jacksonville, USA
3 shared publications Armando Rosales-Velderrain
2 shared publicationsJohn Stauffer
2 shared publications
Latest Publications
- 1 June 2015
- Published by Elsevier in Surgical Clinics of North America
- Vol. 95 (3) , 669-681
Esophageal Strictures and Diverticula
- 1 June 2015
- Published by Elsevier in Surgical Clinics of North America
- Vol. 95 (3) , 669-681
Esophageal Strictures and Diverticula
- 1 April 2014
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 218 (4) , 776-781
Introduction of Mechanical Sphincter Augmentation for Gastroesophageal Reflux Disease into Practice: Early Clinical Outcomes and Keys to Successful Adoption
A new device for mechanical sphincter augmentation (MSA) of the lower esophageal sphincter was approved by the FDA on March 22, 2012. We report early experience with MSA, specifically addressing postoperative management. Between October 1, 2011 and June 1, 2013, 150 patients were evaluated for MSA. Of these, 66 patients underwent device implantation; the first implant was April 10, 2012. All patients had objectively confirmed gastroesophageal reflux disease (GERD) with pH testing, acceptable esophageal motility, and no significant hiatal hernia (>3 cm). All patients experienced clinical improvement on antisecretory medication, but incomplete symptom control or medication intolerance. All patients were successfully implanted without intra- or perioperative complications. Average length of hospital stay was 0.7 days. At an average follow-up of 5.8 months (range 1 to 18.6 months), 92% of patients are satisfied or neutral with their GERD condition, and 83% are proton pump inhibitor free. The GERD-Health-Related Quality of Life (HRQL) scores are similar to those of patients without GERD. There were no device ulcers or erosions and no devices explanted. Thirteen patients underwent additional testing for dysphagia or persistent symptoms. Calls with questions and nursing involvement in the first 6 months postoperatively were 3 times what is typical for fundoplication patients. Dysphagia and regurgitation were the most common concerns. All these symptoms were improving over time. Single-center early results are promising and parallel those from a multicenter trial. There is significant interest in MSA, with referrals and direct patient appointments specifically for MSA. Outcomes improve over time after implantation. The surgeon learning curve is different than with the Nissen, both in operative technique and postoperative management. This is a promising new offering for patients with GERD, and surgeons will need to learn how to integrate this into their practices.
- 1 April 2014
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 218 (4) , 776-781
Introduction of Mechanical Sphincter Augmentation for Gastroesophageal Reflux Disease into Practice: Early Clinical Outcomes and Keys to Successful Adoption
A new device for mechanical sphincter augmentation (MSA) of the lower esophageal sphincter was approved by the FDA on March 22, 2012. We report early experience with MSA, specifically addressing postoperative management. Between October 1, 2011 and June 1, 2013, 150 patients were evaluated for MSA. Of these, 66 patients underwent device implantation; the first implant was April 10, 2012. All patients had objectively confirmed gastroesophageal reflux disease (GERD) with pH testing, acceptable esophageal motility, and no significant hiatal hernia (>3 cm). All patients experienced clinical improvement on antisecretory medication, but incomplete symptom control or medication intolerance. All patients were successfully implanted without intra- or perioperative complications. Average length of hospital stay was 0.7 days. At an average follow-up of 5.8 months (range 1 to 18.6 months), 92% of patients are satisfied or neutral with their GERD condition, and 83% are proton pump inhibitor free. The GERD-Health-Related Quality of Life (HRQL) scores are similar to those of patients without GERD. There were no device ulcers or erosions and no devices explanted. Thirteen patients underwent additional testing for dysphagia or persistent symptoms. Calls with questions and nursing involvement in the first 6 months postoperatively were 3 times what is typical for fundoplication patients. Dysphagia and regurgitation were the most common concerns. All these symptoms were improving over time. Single-center early results are promising and parallel those from a multicenter trial. There is significant interest in MSA, with referrals and direct patient appointments specifically for MSA. Outcomes improve over time after implantation. The surgeon learning curve is different than with the Nissen, both in operative technique and postoperative management. This is a promising new offering for patients with GERD, and surgeons will need to learn how to integrate this into their practices.
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Tu1817 Linx Reflux Management System: An Early Single Center Experience
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Tu1817 Linx Reflux Management System: An Early Single Center Experience
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
782 The Association of Proton Pump Inhibitor Use on the Incidence of Erosive Esophagitis
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
782 The Association of Proton Pump Inhibitor Use on the Incidence of Erosive Esophagitis
- 22 November 2012
- Published by Elsevier in Journal of Surgical Research
- Vol. 182 (2) , 235-240
Variability of NSQIP-assessed surgical quality based on age and disease process
- 22 November 2012
- Published by Elsevier in Journal of Surgical Research
- Vol. 182 (2) , 235-240
Variability of NSQIP-assessed surgical quality based on age and disease process
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Gastrointestinal Resource Utilization After Gastric Bypass
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Gastrointestinal Resource Utilization After Gastric Bypass